Latest updates for Galzus Research
Fresh curated links around Galzus Research are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Immuneering Corporation: Updates Inbound At The End Of The Month
- Maralixibat Improves Xanthomas and Hypercholesterolemia in Children with Alagille Syndrome: A Post Hoc Integrated Analys
- Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Maralixibat Improves Xanthomas and Hypercholesterolemia in Children with Alagille Syndrome: A Post Hoc Integrated Analys...
To characterize baseline xanthoma prevalence and severity in Alagille syndrome, assess their impact on quality of life, evaluate longitudinal changes in xanthoma burden with marali...
Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow
Glaucoma UK Impact Report 2025
Type of impact: Knowledge creation (publications); tools and methods (biorepository, tool kits); dissemination (engagement activities); collaborations; supporting researchers (earl...
Samsung and Massachusetts General Hospital Launch Joint Study To Investigate GLP-1 Treatment Monitoring With Galaxy Watc...
Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) today jointly announced a research study to investigate the efficacy of Galaxy Watch in...
Pegcetacoplan Prophylaxis for Recurrent C3 Glomerulopathy with Multifactorial Genetic Background
A 9-month-old female infant with no family history of kidney disease was admitted in 2014 for macroscopic haematuria. Laboratory tests showed normal renal function (eGFR sec. Schwa...
Hydrogel-Based Axon Model Improves Early Testing for MS Remyelination Therapies
The team engineered vertical micropillars—each tens of times thinner than a human hair—using a microfabrication process called photolithography that allowed them to precisely tune...
Reliability And Testing Of AOD 5MG In Laboratory Models
Scientific breakthroughs are never the result of guesswork; they are the product of rigorous methodology and verified materials. In the study of metabolic health, the use of target...
Gmppb Mutation Rescued by GSK3β Inhibition or Gene Therapy
In a groundbreaking study poised to redefine therapeutic strategies for muscular dystrophies, a team of researchers led by Fu, Wang, and Zhang have unveiled compelling evidence tha...
Current Clinical Trials of Alzheimer’s Drugs
This month, a group of researchers published an annual report on the clinical trials that are testing drugs for Alzheimer’s disease. Overall, they reported an increase in the numbe...
Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hosp...
Collaboration with leading European orthopedic center in Italy supports GelrinC® clinical adoptionRenowned cartilage regeneration expert Prof. Elizaveta Kon to help lead Regentis C...
Alkali-Ion Enhanced Zeolitic Imidazolate Glasses
In a groundbreaking advancement that could reshape the future of materials science, researchers have uncovered new insights into the realm of zeolitic imidazolate framework (ZIF) g...
میٹا اسمارٹ گلاسز سے نجی زندگی متاثر ہونے کا انکشاف، تحقیقات کا آغاز
نیروبی : ٹیکنالوجی کمپنی میٹا کے رے بین اسمارٹ گلاسز نے نئے مسائل پیدا کردیے، کینیا نے ان گلاسز کے خلاف رازداری (پرائیویسی) خدشات کے پیشِ نظر تحقیقات کا آغاز کردیا گیا ہے۔ کینیا کے...
157 CLINICAL POTENTIAL OF BLOOD SAMPLE-BASED DIAGNOSTIC TEST FOR BILE ACID DIARRHEA
AAN 2026: GA Depot may help stabilize disability in RMS and PPMS
Mapi Pharma’s long-acting formulation of glatiramer acetate, GA Depot, may help stabilize disability scores over time in people with both relapsing forms of multiple sclerosis (MS)...
IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference
Research highlights advanced imaging analytics that may support Alzheimer's disease monitoring, patient stratification, and future therapeutic development.
Targeted Therapy Advances in H3K27-Altered Glioma
In an era where cancer research continually pushes the boundaries of personalized medicine, a groundbreaking study has emerged, promising newfound hope for patients suffering from...
Bridging Genetics and Bedside Decisions in IBD: Utility Metrics for Susceptibility PGS
Argenx
Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript
Small Molecule Drug Candidate Completely Restores Survival in Lethal Mouse Model of Rare Kidney Stone Disease with No Ex...
A groundbreaking discovery from the Buck Institute for Research on Aging may soon rewrite the medical landscape for patients suffering from Primary Hyperoxaluria Type 2 (PH2), an a...
159 IMPAIRED CA2+ WAVE PROPAGATION UNDERLIES GALLSTONE DISEASE IN MICE FED A LITHOGENIC DIET
Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomizat...
by Guoqiang Li, Fu Jianhan, Jiashu Gu, Yinhuai Wang, Jiachen Liu, Dong Yang, Dianjie Zeng, Pengcheng Zhao Glomerulonephritis (GN) is an immune-mediated kidney disorder that causes...
<![CDATA[Changing the Standard of Care for Lupus Treatment: Q&A with Albert T. Roy]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.